|Day Low/High||270.40 / 282.99|
|52 Wk Low/High||250.21 / 342.26|
Some of the best opportunities are in lesser-known niche markets such as medical devices and services.
It's no secret that the Fed would like to get out of the short-term repo business.
The charts of TMO are positive.
The Defense Department's potential $10 billion award for their cloud computing contract is a never ending saga with Microsoft and Amazon as finalists.
In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.
Watch closely as the government opens a broad antitrust investigation into unidentified leading online technology platforms
United Parcel Service EPS: beat Revs: beat, +3.4% y/y Record profit across all segments Raised guidance AT&T EPS: in line Revs: in line, +15.3% y/y Subscriber losses Raised guidance for free cash flow General Dynamics EPS: beat Revs: beat, +4.0%...
Bitcoin, the most famous of all crypto-currencies, has enjoyed something of a rebound of late.
The myriad names in oncology have been the hottest area for acquisitions along with gene therapy.
I think we can all agree that there will be no increase made to the Fed Funds Rate today.
Let's check the charts and indicators.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
This options strategy on SBUX offers potential reward with little risk.
The crash of oil will only accelerate the move.
There is likely more headline risk to our front than to our rear.
Who, out there in the health care sector, is safe?
It's hard to understand the magnitude of the change.
You can make a case to buy any of the stocks of the companies at ICR.
These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.
It looks like China is building again.
All the great stocks have artificial intelligence and e-commerce in common.